We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-12.49%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$48.6B
AUM Growth
-$4.2B
Cap. Flow
+$3.6B
Cap. Flow %
7.4%
Top 10 Hldgs %
10.29%
Holding
4,108
New
835
Increased
963
Reduced
740
Closed
743

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$340M
2
BAC icon
Bank of America
BAC
+$302M
3
CI icon
Cigna
CI
+$294M
4
TSM icon
TSMC
TSM
+$275M
5
UNP icon
Union Pacific
UNP
+$256M

Top Sells

Rank Stock Value
1
VZ icon
Verizon
VZ
+$426M
2
SPGI icon
S&P Global
SPGI
+$413M
3
BKNG icon
Booking.com
BKNG
+$264M
4
CMCSA icon
Comcast
CMCSA
+$256M
5
TFX icon
Teleflex
TFX
+$241M

Sector Composition

Rank Sector Weight
1 Healthcare 17.59%
2 Financials 16.96%
3 Technology 16.37%
4 Consumer Discretionary 9.32%
5 Industrials 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KAIR
676
DELISTED
Kairos Acquisition Corp. Class A Ordinary Shares
KAIR
$13.3M 0.03%
1,350,251
PSPC
677
DELISTED
Post Holdings Partnering Corporation
PSPC
$13.3M 0.03%
1,371,746
+1,000
+0.1% +$9.73K
INFN
678
DELISTED
Infinera Corporation Common Stock
INFN
$13.2M 0.03%
2,454,545
+1,783,993
+266% +$11.4M
ESS icon
679
Essex Property Trust
ESS
$18.5B
$13.1M 0.03%
50,265
+48,005
+2,124% +$14.5M
AGGR
680
DELISTED
Agile Growth Corp
AGGR
$13.1M 0.03%
1,336,208
-29
-0% -$284
LVRA
681
DELISTED
Levere Holdings Corp. Class A Ordinary Shares
LVRA
$13.1M 0.03%
1,334,992
EVH icon
682
Evolent Health
EVH
$447M
$13M 0.03%
423,735
+59,705
+16% +$1.74M
EMB icon
683
CALL
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.7B
$13M 0.03%
+152,500
New +$13.8M
AEON icon
684
AEON Biopharma
AEON
$13.5M
$13M 0.03%
18,418
PFE icon
685
PUT
Pfizer
PFE
$153B
$13M 0.03%
247,600
+214,200
+641% +$10.9M
BACA
686
DELISTED
Berenson Acquisition Corp. I
BACA
$13M 0.03%
1,326,835
GGMC
687
DELISTED
Glenfarne Merger Corp. Class A Common Stock
GGMC
$12.9M 0.03%
1,328,138
SWET
688
DELISTED
Athlon Acquisition Corp. Class A Common stock
SWET
$12.9M 0.03%
1,308,916
AGNC icon
689
AGNC Investment
AGNC
$12.9B
$12.8M 0.03%
1,158,961
+1,007,166
+664% +$11.9M
AISP
690
Airship AI Holdings
AISP
$71.3M
$12.7M 0.03%
1,292,726
KIII
691
DELISTED
Kismet Acquisition Three Corp. Class A Ordinary Shares
KIII
$12.7M 0.03%
1,298,036
-27
-0% -$264
MVLA
692
DELISTED
Movella Holdings Inc. Common Stock
MVLA
$12.7M 0.03%
1,292,201
AMLX icon
693
Amylyx Pharmaceuticals
AMLX
$2.54B
$12.7M 0.03%
658,373
+73,909
+13% +$877K
CNR
694
DELISTED
Cornerstone Building Brands, Inc.
CNR
$12.7M 0.03%
517,647
+358,857
+226% +$8.75M
GSL icon
695
Global Ship Lease
GSL
$1.53B
$12.7M 0.03%
766,952
+334,517
+77% +$7.37M
HZNP
696
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$12.6M 0.03%
158,495
-499,611
-76% -$47.3M
NEM icon
697
Newmont
NEM
$119B
$12.6M 0.03%
+211,773
New +$15M
FTEV
698
DELISTED
FinTech Evolution Acquisition Group
FTEV
$12.6M 0.03%
1,289,141
UHG
699
DELISTED
United Homes Group
UHG
$12.6M 0.03%
1,284,990
+49,706
+4% +$488K
HCAR
700
DELISTED
Healthcare Services Acquisition Corporation Class A Common Stock
HCAR
$12.6M 0.03%
1,283,186
+15,589
+1% +$153K

Similar funds

Marshall Wace's Q2 2022 Portfolio in Review

As of Q2 2022, Marshall Wace held 4,108 positions worth $48.6B, down 8% from $52.8B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Marshall Wace deployed $3.6B of net new capital in Q2 2022, opening 835 new positions and adding to 963 existing holdings. Its largest new stake was Eli Lilly: 1,133,393 shares worth $367M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Verizon, an estimated $426M trimmed.

  • Marshall Wace's largest Q2 2022 buy was Eli Lilly: 1,133,393 shares worth $367M.
  • Marshall Wace added most to Bank of America in Q2 2022, an estimated $302M increase.
  • Marshall Wace's biggest Q2 2022 reduction was Verizon, cutting an estimated $426M.
  • Marshall Wace fully exited Teleflex in Q2 2022, selling an estimated $241M.
  • Marshall Wace's ten largest holdings make up 10% of its $48.6B portfolio in Q2 2022.
  • Marshall Wace opened 835 new positions and closed 743 in Q2 2022.
  • Marshall Wace's portfolio value fell 8% quarter-over-quarter to $48.6B.

Based on Marshall Wace's 13F filing for Q2 2022, filed 15 Aug 2022.